NCT05759767

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Mansoura University · Academic / Other
• Sex: All
• Age: 5 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the clinical efficacy and safety of MET after ESWL in pediatric urolithiasis.

Conditions

• Tamsulosin
• Extracorporeal Shock Wave Lithotripsy
• Stone, Kidney
• Stone, Urinary
• Pediatric Disorder

Interventions

Type	Name	Description
DRUG	Tamsulosin	Children in this group will receive medical expulsive therapy in the form of (tamsulosin at a dose of 0.01 mg/kg once daily for 3 weeks after ESWL session.
DRUG	Placebo	Children in this group will receive placebo once daily for 3 weeks after ESWL session.

Timeline

• Start date: 2021-02-01
• Primary completion: 2023-12-01
• Completion: 2023-12-01
• First posted: 2023-03-08
• Last updated: 2023-03-10

Locations

1 site across 1 country: Egypt